1. Home
  2. HAE

HAE

Haemonetics Corporation

Logo Haemonetics Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Founded: 1971 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 4.3B IPO Year: 1991
Target Price: $102.50 AVG Volume (30 days): 469.2K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 2.46 EPS Growth: 32.97
52 Week Low/High: $70.74 - $95.26 Next Earning Date: 05-09-2024
Revenue: $1,270,181,000 Revenue Growth: 12.48%
Revenue Growth (this year): 11.92% Revenue Growth (next year): 5.81%

Share on Social Networks: